Lorenz Life Sciences Group
Lorenz Life Sciences Group is a Frankfurt-based, privately held software company founded in 1989 that provides Regulatory Information Management (RIM) solutions — including docuBridge, eValidator, drugTrack, and Automator — to pharmaceutical companies and 19 health authorities worldwide, with 1,800+ installations across 48 countries.
- Company typePrivate
- Founded1989
- HeadquartersFrankfurt, Germany
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Lorenz Life Sciences Group does
Lorenz Life Sciences Group (legal entity LORENZ Archiv-Systeme GmbH) is a privately held German software company founded in 1989 and headquartered in Frankfurt am Main, with 101-250 employees and wholly-owned subsidiaries including LORENZ Bridge Software GmbH and LORENZ Life Sciences GmbH. The company develops Regulatory Information Management (RIM) software for the life sciences industry, with core products including docuBridge (submission management and regulatory content management), eValidator (submission validation against health authority specifications), drugTrack (product information and lifecycle management, including IDMP/PMS and EUDAMED support), and Automator (business process automation), complemented by verifAI (an AI-assisted content validation add-on using Meta LLaMA 3 on AWS). The platform supports the full regulatory lifecycle from submission assembly through validation, publishing, and post-publishing activities, with deployment available via on-premise or LORENZ Cloud (Microsoft Azure, servers in Germany).
Lorenz serves two primary customer segments: pharmaceutical and biotech companies that compile and submit regulatory dossiers, and government health authorities that receive, validate, and review those submissions. The company reports 1,800+ paid installations across 48 countries and 19 health authorities in its installed base, including the US FDA, Health Canada, the Chinese NMPA, German BfArM, UK MHRA, Singapore HSA, and the European Directorate for the Quality of Medicines & Healthcare (EDQM). Distribution is primarily through direct enterprise sales supplemented by a regional partner network (e.g., Inpharmatis for Eastern Europe and Central Asia) and consortium models for national deployments (e.g., Singapore HSA with VRG and Websparks).
The company operates a subscription/enterprise licensing model with twice-yearly major releases and regulatory update packages, and revenue figures are not publicly disclosed. Marketing is centered on annual LORENZ Converge (in-person conference, Frankfurt 2026), LORENZ Connect (virtual conference reaching ~500 participants across 40 countries), the LORENZ TV video platform, and active LinkedIn and blog presence. The leadership team includes Wolfgang Witzel as President, Raoul-A. Lorenz as founder/legal representative, and Yaprak Eisinger as Managing Director for North America.
Lorenz Life Sciences Group firmographics
Firmographics- Name
- Lorenz Life Sciences Group
- Legal name
- LORENZ Archiv-Systeme GmbH
- Website
- https://lorenz.cc
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Lorenz Life Sciences Group is a Frankfurt-based, privately held software company founded in 1989 that provides Regulatory Information Management (RIM) solutions — including docuBridge, eValidator, drugTrack, and Automator — to pharmaceutical companies and 19 health authorities worldwide, with 1,800+ installations across 48 countries.
- Ownership category
- akta.pro rank
Lorenz Life Sciences Group industry classification
Industry- Product category
- Life Sciences Regulatory Information Management Software
- NAICS
- Software Publishers (5132), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)
- akta.pro secondary industry
- Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)
Keywords
Where Lorenz Life Sciences Group is headquartered
LocationHeadquarters
- HQ city
- Frankfurt
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Lorenz Life Sciences Group business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licensing and Subscription: Enterprise software licensing model with major releases twice yearly (April and October) and minor releases. The company offers cloud and on-premise deployment options. Regulatory Update Packages address specification updates without full software updates.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Lorenz Life Sciences Group product offering
Product offeringCore offering
Lorenz Life Sciences Group develops and sells the LORENZ RIM (Regulatory Information Management) software platform used by pharmaceutical companies, biotech firms, and health authorities worldwide. Its core offerings are docuBridge for assembling, publishing, and managing eCTD regulatory submissions; eValidator for technical compliance validation of incoming submissions; and drugTrack for product information management, IDMP/PMS compliance, and EUDAMED medical device registration.
Product overview
LORENZ Life Sciences Group offers a modular Regulatory Information Management (RIM) platform with core products including docuBridge (submission management and regulatory content management), eValidator (submission validation), and drugTrack (product information and lifecycle management). These are complemented by add-on modules such as Automator (business automation), verifAI (AI-powered validation), Content Validator, and EPIC (XEVMPD to PMS migration validation). The LORENZ RIM platform provides end-to-end regulatory operations support from submission assembly through validation, publishing, and post-publishing activities. The company serves both pharmaceutical industry and regulatory authorities, with solutions supporting eCTD standards, IDMP/PMS requirements, and EUDAMED compliance.
Differentiator
Problem solved
Functional benefit
Brands
- LORENZ docuBridge: Submission Management & Regulatory Content Management solution
- LORENZ eValidator
- LORENZ drugTrack
- LORENZ Automator
- LORENZ verifAI
- LORENZ EPIC
- LORENZ RIM
Products and services
- LORENZ docuBridge Submission Management and Regulatory Content Management solution used by pharmaceutical companies and health authorities to assemble, approve, publish, and submit regulatory dossiers in eCTD format, including eCTD 4.0 EU.
- LORENZ eValidator Submission validation solution that validates all incoming submissions for technical compliance against regulatory authority specifications.
- LORENZ drugTrack Product Information and Lifecycle Management solution supporting IDMP compliance, PMS enrichment for EMA, EUDAMED registration for medical devices, and regulatory activity management.
- LORENZ Automator Business automation solution that enables process automation and next-generation case management integration for regulatory workflows.
- LORENZ verifAI AI-powered content validation tool that automates review processes by validating eCTD content for accuracy, completeness, and compliance using Meta LLaMA 3 hosted on AWS.
- LORENZ RIM Comprehensive Regulatory Information Management platform encompassing submission management, regulatory content management, product information, lifecycle management, submission validation, and post-publishing capabilities.
- LORENZ EPIC (EV PMS Integrity Check) Validation tool for XEVMPD to PMS migration that provides automated comparison between systems, identifying discrepancies and data quality issues.
Quantifiable outcome
- 27% of world population receives new medicines approved through LORENZ solutions
- +2 more outcomes
Companies that use Lorenz Life Sciences Group
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
Lorenz Life Sciences Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature6 records
Lorenz Life Sciences Group partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- InpharmatiscoreInpharmatis became an official LORENZ Partner authorized to promote and implement LORENZ RIM solutions (docuBridge, drugTrack, eValidator) for pharmaceutical companies in Turkey, Ukraine, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Uzbekistan, Turkmenistan, Mongolia, Latvia, Lithuania, and Estonia. This partnership expands access to LORENZ solutions across Eastern Europe and Central Asia.
- DNAnexuscoreStrategic partnership to offer Trusted Regulatory Spaces - secure, cloud-native environments for collaborative regulatory submission validation and scientific review. The partnership leverages DNAnexus precisionFDA platform and LORENZ eValidator for Project PRISM, a collaboration with FDA to demonstrate collaborative regulatory submission validation and review capabilities.
- precisionFDA (FDA/DNAnexus)coreLORENZ eValidator is deployed on precisionFDA, FDA's production cloud platform built and powered by DNAnexus, enabling sponsors to share eCTD validation results with reviewers using Trusted Regulatory Spaces. This collaboration is part of Project PRISM with FDA and industry collaborators.
- VRG Pte. Ltd.coreConsortium partner with LORENZ and Websparks Pte. Ltd. for the Singapore HSA eCTD Reviewing Solution. VRG provides expertise for the implementation of the complete solution including docuBridge, eValidator, and Automator.
- Websparks Pte. Ltd.coreConsortium partner with LORENZ and VRG Pte. Ltd. for the Singapore HSA eCTD Reviewing Solution. Websparks provides the portal offering component of the complete eCTD solution.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Lorenz Life Sciences Group competitors and assessment
Company assessmentDirect peers
- Ennov: Ennov provides a RIM, QMS, and document management suite targeting mid-market life sciences companies, with comparable eCTD publishing and submission management features to LORENZ.
- EXTEDO: EXTEDO (now part of PharmaLex/DocVerse) is a long-standing direct competitor in eCTD submission publishing and RIM, with comparable health authority and sponsor customer profiles.
- ArisGlobal: ArisGlobal's LifeSphere RIM is a direct competitor to LORENZ's submission management, validation, and product information suite, targeting the same mid-to-large pharma market with a SaaS-first delivery model.
- Amplexor (Acolad Life Sciences): Amplexor (now part of Acolad) offers eCTD, RIM, and life sciences regulatory content solutions with a comparable feature footprint to LORENZ, serving pharma sponsors and health authorities across Europe.
Emerging players
- PharmaLex (Cencora): PharmaLex (now part of Cencora) bundles regulatory consulting with the EXTEDO RIM platform, making it a peer in the combined software-plus-services regulatory value chain that LORENZ competes with.
- MasterControl: MasterControl provides quality management and regulatory document management solutions for life sciences. It overlaps with LORENZ on regulatory content management and GxP documentation but emphasizes QMS rather than submission publishing.
Broad incumbents
- IQVIA: IQVIA offers regulatory information management and RIM outsourcing as part of its broader clinical and commercialization technology stack. It competes with LORENZ for both sponsor and health authority business, and bundles RIM with adjacent CRO/CDM services.
- Veeva Systems: Veeva's Vault RIM suite is the dominant cloud-native regulatory platform for large pharmaceutical sponsors. Veeva competes directly with LORENZ docuBridge/eValidator/drugTrack and has substantially greater scale and brand recognition in the same buyer segment.
- Oracle Health Sciences (formerly Oracle Argus/Inform): Oracle's clinical and regulatory suite (including the former goBalto, Medidata, and Siebel CTMS assets) competes with LORENZ in the broader pharma software stack, particularly with large sponsors standardizing on Oracle Cloud.
- DXC Technology (formerly CSC Life Sciences): DXC's life sciences practice offers regulatory information management and submission services as part of a broader IT services portfolio, competing with LORENZ particularly for large health authority transformation deals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Lorenz Life Sciences Group social profiles
Digital presenceLorenz Life Sciences Group compliance and trust
Trust signalCompliance2 records
Lorenz Life Sciences Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lorenz Life Sciences Group leadership team
Management profileNumber of profiles
Profiles3 records
Lorenz Life Sciences Group subsidiaries and ownership
Company hierarchySubsidiaries2 records
Lorenz Life Sciences Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lorenz Life Sciences Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lorenz Life Sciences Group
What does Lorenz Life Sciences Group do?
Lorenz Life Sciences Group develops and sells the LORENZ RIM (Regulatory Information Management) software platform used by pharmaceutical companies, biotech firms, and health authorities worldwide. Its core offerings are docuBridge for assembling, publishing, and managing eCTD regulatory submissions; eValidator for technical compliance validation of incoming submissions; and drugTrack for product information management, IDMP/PMS compliance, and EUDAMED medical device registration.
Is Lorenz Life Sciences Group a public or private company?
Lorenz Life Sciences Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lorenz Life Sciences Group founded?
Lorenz Life Sciences Group was founded in 1989. It employs 101 to 250 people.
Where is Lorenz Life Sciences Group based?
Lorenz Life Sciences Group is headquartered in Frankfurt, Germany, in the Europe region.
How does Lorenz Life Sciences Group make money?
One revenue line is on record: software Licensing and Subscription.
Who are Lorenz Life Sciences Group's main competitors?
Direct peers on record are Ennov, EXTEDO, ArisGlobal and Amplexor (Acolad Life Sciences). Emerging players are PharmaLex (Cencora) and MasterControl. Broad incumbents are IQVIA, Veeva Systems, Oracle Health Sciences (formerly Oracle Argus/Inform) and DXC Technology (formerly CSC Life Sciences).
Does Lorenz Life Sciences Group have an API?
Yes. LORENZ provides PMS (Product Management Service) API Write Access for EMA's PMS system, enabling direct data enrichment submissions to EMA's PMS Production system without manual data entry. This API allows authorized users to validate, enrich, and update PMS data directly from within drugTrack. The PMS API Write Access has been live since September 25, 2025.
What industry is Lorenz Life Sciences Group in?
Lorenz Life Sciences Group's product category is Life Sciences Regulatory Information Management Software. Its primary akta.pro industry code is HLAGAJAL, Regulatory Information Management (RIM) & Submission Publishing Software, with a secondary code of HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management). Its NAICS code is 5132 and its SIC code is 8731.